GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: Lolamicin is an antibacterial with potential to avoid disruption of the gut microbiota. It has specific activity against Gram-negative pathogenic bacteria, while selectively sparing Gram-negative and Gram-positive commensal strains [2]. Lolamicin is an inhibitor of lipoprotein CDE (LolCDE) [2], a complex found in the membrane of Gram-negative bacteria. It is one of the chemical structures claimed in patent WO2023091873A1 from the University of Illinois [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 3-[[3-[4-(2,6-dimethylpyridin-4-yl)-1H-pyrazol-5-yl]phenoxy]methyl]benzonitrile |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Lolamicin |
| Other databases | |
| GtoPdb PubChem SID | 496703380 |
| PubChem CID | 168894634 |
| Search Google for chemical match using the InChIKey | CIXIQLLJOWEAKU-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | CIXIQLLJOWEAKU |
| UniChem Compound Search for chemical match using the InChIKey | CIXIQLLJOWEAKU-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | CIXIQLLJOWEAKU-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
Lolamicin (links to external site)
Cat. No. HY-164036 |